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Uterine ﬁbroids are common in women of reproductive age and various conservative treatments are available. In order to achieve
a successful conservative treatment of ﬁbroids, functional integrity of the uterus is as important as tumor removal or symptoms
relief. In this context, intrauterine adhesions must be recognized as a possible complication of conservative management of
uterine ﬁbroids, but diagnostic pitfalls might justify an underestimation of their incidence. Hysteroscopic myomectomy can cause
adhesions as a result of surgical trauma to the endometrium. The average reported incidence is around 10% at second-look
hysteroscopy, but it is higher in certain conditions, such as the case of multiple, apposing ﬁbroids. Transmural myomectomies
also have the potential for adhesion, especially when combined with uterine ischemia. Uterine arteries embolization also carries
a risk of intracavitary adhesions. Prevention strategies including bipolar resection, barrier gel or postoperative estradiol, might
be useful, but stronger evidence is needed. In view of current knowledge, we would recommend a prevention strategy based on a
combination ofsurgical traumaminimization and identiﬁcation ofhigh-riskcases.Earlyhysteroscopicdiagnosis andlysis possibly
represents the best means of secondary prevention and treatment of postoperative intrauterine adhesions.
1.Introduction
Uterine ﬁbroids are an extremely common ﬁnding in women
of reproductive age, and various conservative treatment
approaches are available.
Indications to conservative treatment might be repre-
sented by the patient’s wish to avoid a hysterectomy or to
preserve or enhance her reproductive potential.
In the latter case, functional integrity of the uterus is as
important as the complete removal of the ﬁbroid tumors or
symptoms relief, in terms of surgical outcomes and success.
Women, undergoing major gynaecological surgery, have
a high risk of developing postoperative adhesions of some
extent [1]. This circumstance, although commonly consid-
ered inevitable, represents a short-/long-term complication
of surgery, with important repercussions on patients’ health
and quality of life, as well as relevant direct and indirect costs
for the healthcare systems [2].
Adhesions in gynecology have a particular relevance, be-
cause of the potential impact on reproductive function, on
top of the known consequences, such as abdominal/pelvic
pain or bowel obstruction. Therefore, medical literature of
the last decades has dedicated great attention to the topic
of adhesion prevention after “gynaecological surgery” by
focusing on peritoneal adhesion, but not on intracavitary
adhesions [3]. Nevertheless, intrauterine adhesions are a
possible complication of therapeutic procedures on the
uterus and, although often silent, can interfere with fertility
and always hide the potential of becoming symptomatic, for
example, the Asherman’s syndrome.
This paper focuses on intrauterine adhesions that might
occur as a result of conservative management of uterine ﬁ-
broids.
2. IntrauterineAdhesions following
Treatment of Submucous Fibroids
Hysteroscopic myomectomy is currently the gold standard
for the surgical treatment of submucosal ﬁbroids, having2 Obstetrics and Gynecology International
replaced traditional surgical approaches such as hysterec-
tomy and abdominal myomectomy. It was ﬁrst described in
1976 by Neuwirth and Amin, who used an urologic resect-
oscope [4], while the ﬁrst report of a gynaecological in-
strument came by Hallez in 1987 [5]. Resectoscopic my-
omectomy is safe and eﬀective in removing ﬁbroids and
treating related symptoms [6], and a wide range of instru-
ments is now available [7].
As any other intrauterine operation, hysteroscopic myo-
mectomy can cause adhesions as a result of surgical trauma
to the endometrium. Hysteroscopic surgery is commonly
considered as a minor risk when compared with the inter-
ventions with the highest adhesiogenic potential, such as
dilatation and curettage (D and C) following delivery or
miscarriage [8]. Nevertheless, pitfalls in the diagnosis of
postoperative intrauterine adhesions might cause an under-
estimation of the problem, and a second-look hysteroscopy
would be needed to calculate the real incidence (Table 1).
In a prospective study by Taskin et al., a second-look
diagnostic hysteroscopy showed mild intrauterine adhesions
in the 37.5% of patients after monopolar resection of a
single ﬁbroid, and in the 45% after resection of multiple
ﬁbroids [9]. Interestingly, a lower incidence of adhesions was
reported by the same study following the resection of polyps
(3.6%) or uterine septa (6.5%), and no diﬀerences were
found between patients who were pretreated with danazol
and untreated ones. The incidence of adhesions reported by
Taskin et al. is deﬁnitely high but could be justiﬁed by the
short interval between primary surgery and hysteroscopic
followup. As a matter of fact, the latter was conducted
between 14 and 30 days after the ﬁbroid resection, and the
same Authors reported doubts whether the adhesions were
“de novo”, or part of the normal healing process.
In contrast with those ﬁndings, Yang et al. report a low
rate of 1.5% of adhesions at 1-to-3-month hysteroscopic
second look following the removal of a single submucous
ﬁbroid, while, in their experience, adhesion rate after
resection of apposing ﬁbroids reaches the 78%, in spite of
the insertion of an intrauterine device (IUD) postoperatively
[10]. Interestingly, a subgroup of seven patients, who were
operated for multiple apposing ﬁbroids and did not receive
an IUD, underwent an early lysis of adhesions at 1-2 weeks
from the primary surgery, and none of them presented with
adhesions at the scheduled 1–3-month second look.
In the setting of a larger, randomized study on the
prevention of adhesions with auto-cross-linked hyaluronic
acid gel following resectoscopic surgery, Guida et al. diag-
nosed postoperative adhesions in one fourth of patients
submitted to ﬁbroid resection [11]. However, the rate of
adhesions, detected at a 3-month hysteroscopic second look,
was signiﬁcantly lower when auto-crossed hyaluronic acid
gel was used following ﬁbroid resection (16% cases versus
33.33% controls), although larger, and adequately powered,
trials would be needed to conﬁrm this ﬁnding. In this
study, the ﬁbroid resections were accomplished with bipolar
resectoscopes. These instruments are currently replacing
the older generation of monopolar instruments because of
the invaluable advantage of using an electrolyte-containing
isotonic distension medium such as normal saline. The
reduction of the risks of electrolyte imbalance related to
ﬂuid overload [12] increases the safety proﬁle of this kind
of surgery.
A role of bipolar resectoscopes in reducing the risk of
postoperative intrauterine adhesions has been suggested by
Touboul et al. [13]. These Authors reported the ﬁndings
of systematic second-look hysteroscopy following bipolar
hysteroscopic myomectomy, demonstrating synechiae only
in 4 out of a group of 53 infertile patients (7.5%). The
latter evidence is anyway weak and not supported by
comparative studies. Moreover, low rates of intrauterine
adhesions have also been reported following monopolar
resection of ﬁbroids.
Roy et al., for instance, retrospectively analyzed the two-
month second-look hysteroscopy in 186 patients with infer-
tility and recurrent abortions submitted to myomectomy
with monopolar resectoscope, showing adhesions in only 2
patients (1.07%) [14]. However, all the patients in this study
had received intra and postoperative antibiotic prophylaxis,
as well as a course of estradiol valerate, 2mg per day, during
30 days.
Finally, in a series of ﬁve patients with diﬀuse uterine
leiomiomatosiswhounderwentselectivehysteroscopicresec-
tion, published by Yen et al. in 2007, postoperative intra-
cavitary adhesions were found in 2 cases [15]. Interestingly,
one out of those two patients had developed hypomenorrhea
and had repeat hysteroscopic adhesiolysis, but also conceived
spontaneously at 4 months following the last surgery, and
eventually delivered an healthy infant (cesarean section for
breech presentation) after an uneventful pregnancy.
3. IntrauterineAdhesions following
TreatmentofIntramuralFibroids
The potential role of hysteroscopic ﬁbroid surgery in induc-
ingintrauterinesynechiaeisobvious.Nonetheless,alsoother
conservative treatments of uterine ﬁbroids might lead to
intracavitary adhesions.
Myomectomy, both abdominally and laparoscopically,
is a common and safe conservative surgical procedure for
intramural ﬁbroids, especially in women of reproductive age
[16] .T h em e d i c a ll i t e r a t u r ep r o v e si t sr o l ei ns y m p t o mr e l i e f
and fertility preservation, although it is still debated as a
purely fertility-enhancing procedure in infertile patients.
The occurrence of abdominal and pelvic adhesions as
a complication of open or laparoscopic ﬁbroid enucleation
is well documented [17]. On the contrary, intrauterine
synechiae are not commonly addressed as a potential risk
of myomectomy. Indeed, reasonable evidence exists on the
development of adhesions following transmural surgery,
such as caesarean sections or abdominal myomectomy [18,
19].
The overall risk following myomectomy is considered
low (1.3%) [20], but the heterogeneity of this kind of
surgery (e.g., not all the ﬁbroids are transmural, and not
all the abdominal myomectomies require the opening of the
endometrial cavity) makes it diﬃcult to study the association
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Table 1: Intrauterine synechiae following resectoscopic myomectomy. Second-look hysteroscopy.
Author Instrument Second-look
interval Fibroids Additional treatment Adhesions/second-look
hysteroscopies Adhesion rate
Taskin et al.
2000 [9]
monopolar 14–30 days
single
no/placebo 8/22 36.36%
Danazol 7/20 35%
multiple
no/placebo 6/13 46.15%
Danazol 6/14 42.85%
Guida et al.
2004 [11]
bipolar 3 months single∗
no/placebo 8/24 33.33%
a–c hyaluronic acid gel 4/25 16%
Yang et al.
2008 [10]
monopolar∗ 1–3 months
single No 2/132 1.5%
2, nonapposing IUD, 1 month 0/5 0%
≥2 apposing IUD, 1 month 7/9 78%
≥2 apposing early lysis 1-2 weeks 0/7 0%
Touboul et
al. 2009 [13] bipolar 2 months single∗ No 4/53 7.5%
Roy et al.
2010 [14] monopolar 6 weeks single estradiol valerate (6 weeks)
antibiotics (5 days) 2/186 1.07%
Total 54/510 10.58%
∗Extrapolated, but not clearly stated on the original paper.
Moreover, synechiae can be seen at hysterosalpingogra-
phy [18] and hysteroscopy [19], but those diagnostic proce-
dures are not routinely used postoperatively. In addition, we
need to be aware of certain groups of patients, or procedures,
that might increase the risk of adhesions.
Several approaches have been studied and proposed
to facilitate myomectomy or reduce feared complications
such as hemorrhage, and the related risk for hysterectomy,
although their potential eﬀect on the uterine cavity has sel-
dom been assessed. Tixier et al. studied the eﬀect of preoper-
ative uterine arteries embolization (UAE) and uterine arter-
ies surgical ligation on the outcomes of laparoscopic or open
myomectomy [21]. The patients wishing to conceive after
myomectomy were submitted to diagnostic hysteroscopy 3
months after surgery. The authors reported an incidence of
18% (4/22) of synechiae in women whose myomectomy had
been preceded by a temporary uterine artery embolization.
On the contrary, no intrauterine adhesions were found
among the cases where the uterine arteries were ligated
intraoperatively by mono- or bilateral reabsorbable clips.
The same measure was 14.8% (4/27) for patients who had
not received any preparation prior myomectomy.
The same research group also reported on retrospective
ﬁndings of hysteroscopic evaluation 3 months following
myomectomy with previous UAE, in patients wishing to
conceive [22]. In that case, three out of the ten patients
presented intrauterine synechiae (30%).
Uterine artery embolization under X-ray guidance is also
the main nonsurgical alternative to myomectomy [23]. It
was initially described in 1995 [24], and it is an eﬀective
treatment in reducing symptoms such as bleeding or pelvic
pain and also induces shrinkage of the tumors [20]. It is
contraindicated in case of intracavitary ﬁbroids, because of a
risk of spontaneous expulsion [25]. UAE is controversial for
fertility wishing patients since long-term eﬀects on ovarian
function and fertility are not known, and complicated
o b s t e t r i c a lo u t c o m e sh a v eb e e nr e p o r t e d[ 26, 27].
I nas t u d yb yM a r ae ta l .o nw o m e no ff e r t i l ea g eu n d e r -
going UAE for symptomatic uterine ﬁbroids, hysteroscopy
performed at 3 to 9 months from the embolization showed a
highprevalenceofpathologicalorabnormalﬁndings,among
which 14% of intrauterine or cervical adhesions (7 out of
51 patients) [28]. These ﬁndings demonstrate that surgical
trauma is not essential for the development of synechiae and
support the doubts existing on the suitability of UAE for
fertilitywishingpatients,inspiteoftheevidenceofsuccessful
pregnancies published in recent years [29].
4. Discussion
While the mechanism of adhesion formation is still largely
unknown, and multiple predisposing and causal factors
are probably implicated, trauma to the endometrium is
commonly considered the major factor in the genesis of
uterine synechiae.
Theendometriumiscomposedoftwolayers,afunctional
layer and an underlying basal layer. The latter is needed
for regenerating the functional layer, which is lost with the
menstruation.Traumatothebasallayercanleadtothedevel-
opment of intrauterine scars resulting in adhesions, which
can obliterate the cavity to varying degrees. A peculiarity of
intrauterine trauma is that it often occurs simultaneously
on apposing surfaces, because of the limited volume of the
cavity. This is quite evident in case of blind procedures,
such as a dilatation and curettage. The association between
trauma, synechiae, and speciﬁc symptoms is what had
already been identiﬁed by Joseph Asherman in the ﬁrst half
of last century (amenorrhoea traumatica)[ 30].4 Obstetrics and Gynecology International
As a consequence of trauma, a tissue healing process
is started, and it can progress by two diﬀerent modalities:
regeneration or repair. Regeneration occurs cyclically after
the menstruation, when the lost tissue is replaced by a
new functional layer, originating by a healthy basal layer.
A repair mechanism, instead, replaces the missing normal
tissue with an extracellular matrix (e.g., ﬁbronectin and
collagen), leading to scar formation. As such scarring could
be considered a failure of tissue regeneration.
Postsurgical adhesions develop in a similar fashion as
scars, that is, within the repair healing process. Initially, the
injury is covered and sealed by ﬁbrin (ﬁlmy, “ﬁbrinous”
adhesions). Most commonly, physiologic ﬁbrinolysis is able
to limit the extent of those ﬁlmy adhesions and dissolve
them. Factors such as a persistent or extended tissue trauma
might disrupt the process of ﬁbrinolysis. When that occurs,
collagen and other matrix substances are produced by repair
cells such as ﬁbroblasts or macrophages, resulting into
permanent ﬁbrous adhesions [31].
Tissue hypoxia is thought to be a factor that potentiates
the initial tissue injury and triggers a cascade of responses
that leads to the creation of adhesions [32, 33]. Hypoxia
negatively aﬀects ﬁbrinolysis [34], and in vitro studies
demonstrate that it also induces irreversible phenotypic
changes in ﬁbroblasts [35].
The current knowledge of the mechanism of adhesion
formation is certainly not exhaustive but justiﬁes the clinical
ﬁndings of higher rate of synechiae following removal
of multiple, apposing ﬁbroids (extended trauma) or UAE
(hypoxia).
Nevertheless, some patients develop adhesions regardless
of the extent of the trauma or other plausible risk factors.
Moreover, the diagnosis of silent intrauterine adhesions is
not straightforward, and we believe that their incidence
might be underestimated. As a matter of fact, the main
diagnostic tool used in gynaecology, ultrasonography, does
not seem to be accurate in diagnosing synechiae, and
hysteroscopy should be considered the gold standard. For
instance, systematic pre-IVF outpatient hysteroscopy in
patients with normal ﬁndings at HSG shows 4.1% of
adhesions, whereas ultrasound could not detect any [36].
Moreover, hysteroscopy identiﬁes intrauterine adhesions in
11% of patients with repeated failure of IVF-ET, none
of them suspected at standard TV ultrasound [37]. It is
still a matter of debate whether infertile patients should
undergo systematically a diagnostic hysteroscopy [38], but
we believe that those at a higher risk of synechiae, such as
following a multiple resection of ﬁbroids, should be oﬀered
an endoscopic assessment of their uterine cavity, which is a
method with high compliance, that can be performed in an
outpatient setting without any need for anesthesia [39].
Prevention of synechiae has not been exhaustively stud-
ied in medical literature. Proposed strategies mostly focus on
etiopathology. For instance, IUDs have been advocated, in
ordertoavoidapposingsurfacespostoperativelybuthavenot
been proven eﬀective [10]. Some authors have also proposed
intrauterineballoons,suchasfoleycatheters,butthebeneﬁts
of these intrauterine devices are not clearly higher than, for
instance, the risk of postoperative infections [40].
Reabsorbable barriers such as auto-cross-linked hyalu-
ronic acid gel have been shown to signiﬁcantly reduce
adhesions’ reformation and severity after hysteroscopic
adhesiolysis [41]a n dm i g h tb ee ﬀective after resectoscopic
myomectomy because of high sensitivity and prolonged
intracavitary residency time [11, 40].
Postoperative treatment with oral estrogens has been
used, in order to stimulate endometrial regeneration [14].
Althoughthepotentialeﬀectofanestrogenicstimulusonthe
endometrium appears logical, available evidence supporting
its use is not strong, and, therefore, they cannot be recom-
mended routinely. On the contrary, it seems reasonable to
avoid, when possible, any iatrogenic hypoestrogenic status,
such as that induced by preoperative GnRH agonists, whose
role in facilitating surgery has been suggested but is still
controversial [3, 42, 43].
Finally, although it has been proposed that infection
might cause adhesions, no evidence supports the prophy-
lactic use of antibiotics for primary hysteroscopic surgery or
synechiolysis [40, 44].
Surgical strategies might also oﬀer ways to prevent syn-
echiae. For instance, resection of apposing ﬁbroids could be
avoided,bytheadoptionoftwo-stepprocedures.Minimizing
tissue trauma by reducing thermal injury and preferring
mechanical instruments is possible during resectoscopic
myomectomy [45]. The use of bipolar resectoscopes is
recommendable because of overall advantages, but we lack
comparative studies to prove their superiority on monopolar
counterparts in terms of postoperative synechiae. Reducing
the size of the instruments could also potentially play a role,
but it is limited by the volume of the ﬁbroids [46, 47].
In case of myomectomies for intramural ﬁbroids, intra-
operative techniques to reduce bleeding, such as those by
endoscopic loops or ligations [48–50], might be preferable
over preoperative UAE [22]. Identiﬁcation and separate
suturing of diﬀerent layers, especially in case of opening of
the endometrial cavity, is recommendable.
Finally, performing a second-look or control hys-
teroscopy as a followup of the primary surgery, especially in
high risk cases, seems to be a feasible and eﬀective way to
diagnose and treat synechiae, often at their early, ﬁbrinous
stage [10].
5. Conclusions
The conservative treatment of ﬁbroids on women of repro-
ductive age is also necessarily a functional treatment. Both
the anatomy and the functionality of the uterus need to
be respected, preserved, and in some cases improved. In
this context, postoperative intrauterine synechiae, although
considered uncommon, must be considered as potentially
serious complications of ﬁbroids’ treatment.
Hysteroscopic resection of ﬁbroids might cause syne-
chiae, especially in the case of multiple, apposing ﬁbroids.
Transmural myomectomies also have adhesiogenic potential,
especially when combined with uterine ischemia. Uterine
arteries embolization cannot be considered a ﬁrst choice forObstetrics and Gynecology International 5
patients with ﬁbroids who wish to conceive, also because it
carries a risk of intracavitary adhesions.
The real occurrence of intrauterine adhesions following
myomectomy might be underestimated because of diagnos-
tic pitfalls and low awareness [51].
Various strategies have been suggested for the prevention
of postoperative uterine synechiae, but we are lacking well-
powered and designed studies to assess their value after
myomectomy or, for instance, UAE.
In view of current knowledge, we recommend a pre-
vention strategy based on a combination of good surgical
practice and awareness of high-risk cases and procedures.
Surgery should minimize the damage to healthy tissue
and avoid simultaneous trauma on apposing endome-
trial surfaces. Identiﬁcation of high-risk patients, followed
by early hysteroscopic diagnosis and lysis of postsurgical
synechiae, possibly represents the best means of secondary
prevention and treatment of intrauterine adhesions.
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